NCT06413381Recruiting
Risk Factors for Non-response to Hormonal Medical Therapy in Patients With Endometriosis
Source: ClinicalTrials.gov · Last updated 1 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Determine the proportion of patients with endometriosis unresponsive to medical therapy and to compare the clinical and ultrasonographic characteristics of this group of patients (study group) with the clinical and ultrasonographic characteristics of patients responsive to medical therapy (control group).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 9 May 2024
- Start date
- 19 Apr 2024
- Primary completion date
- 31 Aug 2028
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Endometriosis
- NCT number
- NCT06413381
What you commit to
- Study type: Observational
- Planned participants: 250
- From 19 Apr 2024 to the primary completion date, 31 Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- current or previous pelvic infections
- previous pelvic surgery (hysterectomy, salpingectomy, ovarian cyst removal, myomectomy, surgery for endometriosis, bowel resections)
Other illness
- history of malignancy or current suspicion of gynecologic malignant lesions
- positive history of other causes of chronic pelvic pain
Other
- patients with contraindications to oral hormone treatment
- post-menopausal status
Who the study is looking for
- age between 18 and 50 years;
- patients with endometriosis-related pain symptoms (dyspareunia, dyschezia, dysmenorrhea, chronic pelvic pain, dysuria, periovulatory pain, with at least one of these symptoms presenting Numerical Pain Rating Scale intensity \> 5);
- indication for administration of oral hormonal medical treatment for endometriosis;
- acquisition of informed consent.
Age in the registry: 18 years to 50 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.